Between 30 to 50 percent of people living with multiple sclerosis (MS) will experience memory problems but the cause is uncertain. Brain lesions are the hallmark imaging sign used to diagnose MS and ...

Roche RHHBY announced new data from the mid-stage study on an experimental candidate, fenebrutinib, for treating relapsing multiple sclerosis (“RMS”). Fenebrutinib is an investigational oral, ...

Between 30 to 50 percent of people living with multiple sclerosis (MS) will experience memory problems but the cause is uncertain. Brain lesions are the hallmark imaging sign used to diagnose MS and ...

Paramagnetic rim lesions may help assess MS risk in people with radiologically isolated syndrome before symptoms appear.

Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost. Actelion has had a bumpy ...

Christina Applegate opened up about the symptoms she’s experienced throughout her battle with Multiple Sclerosis (MS) during a recent podcast interview on Monday, March 25. The sitcom star, 52, was ...

Christina Applegate is revealing more about her health challenges. The "Dead to Me" star, 52, opened up about her battle with multiple sclerosis on Monday's episode of Dax Shepard's "Armchair Expert" ...

The combination of cortical lesions and central vein sign in MRI increases the specificity and sensitivity for diagnosing multiple sclerosis. This study suggests that CLs and CVS, when used together, ...